Apyx Stock Based Compensation from 2010 to 2024

APYX Stock

USD 1.45 0.01 0.69%

Apyx Medical Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

1996-09-30

Previous Quarter

1.1 M

Current Value

997 K

Quarterly Volatility

595.9 K

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Apyx Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Apyx Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 736.2 K, Interest Expense of 2.6 M or Selling General Administrative of 51.3 M, as well as many indicators such as Price To Sales Ratio of 1.65, Dividend Yield of 0.0 or PTB Ratio of 3.23. Apyx financial statements analysis is a perfect complement when working with Apyx Medical Valuation or Volatility modules.

Check out the analysis of Apyx Medical Correlation against competitors.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

Latest Apyx Medical's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Apyx Medical over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Apyx Medical's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Apyx Medical's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Apyx Stock Based Compensation Regression Statistics

	Arithmetic Mean	2,335,500
	Geometric Mean	901,514
	Coefficient Of Variation	101.69
	Mean Deviation	2,139,560
	Median	871,000
	Standard Deviation	2,375,061
	Sample Variance	5.6T
	Range	6.7M
	R-Value	0.92
	Mean Square Error	945.5B
	R-Squared	0.84
	Slope	488,004
	Total Sum of Squares	79T

Apyx Stock Based Compensation History

	2024	5.4 M
	2023	5.1 M
	2022	6.7 M
	2021	5.1 M
	2020	4.2 M
	2019	3.6 M
	2018	1.5 M

Other Fundumenentals of Apyx Medical

Stock Based Compensation To Revenue

Apyx Medical Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.81	0.19	-0.6	0.15	0.67	0.66	-0.45	0.5	1.0	0.71	-0.72	-0.05	0.32	0.66	0.88	-0.58	0.71	-0.69	-0.89	0.92	0.96	0.43
Total Stockholder Equity	0.81		0.43	-0.77	0.63	0.29	0.45	-0.31	-0.1	0.82	0.54	-0.56	0.06	0.23	0.29	0.95	-0.56	0.5	-0.58	-0.74	0.89	0.82	-0.12
Current Deferred Revenue	0.19	0.43		-0.51	0.35	0.03	0.0	-0.26	-0.31	0.21	-0.02	0.02	-0.03	0.17	-0.12	0.27	0.08	0.15	-0.06	-0.07	0.26	0.17	-0.46
Net Debt	-0.6	-0.77	-0.51		-0.46	-0.35	-0.48	0.19	0.11	-0.61	-0.46	0.51	-0.16	-0.17	-0.48	-0.72	0.4	-0.44	0.46	0.61	-0.67	-0.6	0.2
Retained Earnings	0.15	0.63	0.35	-0.46		-0.49	-0.27	0.08	-0.68	0.16	-0.04	-0.01	0.09	-0.12	-0.4	0.51	-0.1	-0.3	-0.03	-0.07	0.42	0.29	-0.67
Accounts Payable	0.67	0.29	0.03	-0.35	-0.49		0.82	-0.35	0.71	0.67	0.6	-0.67	0.04	0.24	0.87	0.41	-0.42	0.82	-0.59	-0.74	0.46	0.55	0.62
Net Receivables	0.66	0.45	0.0	-0.48	-0.27	0.82		-0.3	0.45	0.66	0.74	-0.73	0.11	0.27	0.87	0.53	-0.57	0.83	-0.66	-0.82	0.51	0.56	0.4
Good Will	-0.45	-0.31	-0.26	0.19	0.08	-0.35	-0.3		-0.28	-0.38	-0.18	-0.14	0.78	-0.72	-0.3	-0.17	0.05	-0.18	0.12	0.16	-0.15	-0.22	-0.06
Total Liab	0.5	-0.1	-0.31	0.11	-0.68	0.71	0.45	-0.28		0.48	0.41	-0.39	-0.18	0.21	0.69	0.1	-0.14	0.49	-0.33	-0.41	0.25	0.41	0.92
Total Current Assets	1.0	0.82	0.21	-0.61	0.16	0.67	0.66	-0.38	0.48		0.71	-0.77	0.03	0.24	0.65	0.9	-0.6	0.72	-0.71	-0.9	0.94	0.97	0.42
Short Term Debt	0.71	0.54	-0.02	-0.46	-0.04	0.6	0.74	-0.18	0.41	0.71		-0.63	0.05	0.33	0.68	0.62	-0.56	0.71	-0.65	-0.81	0.67	0.69	0.46
Intangible Assets	-0.72	-0.56	0.02	0.51	-0.01	-0.67	-0.73	-0.14	-0.39	-0.77	-0.63		-0.58	0.27	-0.68	-0.76	0.63	-0.71	0.71	0.88	-0.77	-0.8	-0.4
Common Stock	-0.05	0.06	-0.03	-0.16	0.09	0.04	0.11	0.78	-0.18	0.03	0.05	-0.58		-0.82	-0.02	0.24	-0.38	0.19	-0.19	-0.2	0.18	0.15	-0.04
Property Plant Equipment	0.32	0.23	0.17	-0.17	-0.12	0.24	0.27	-0.72	0.21	0.24	0.33	0.27	-0.82		0.3	0.06	0.06	0.32	-0.17	-0.2	0.11	0.1	0.18
Long Term Debt	0.66	0.29	-0.12	-0.48	-0.4	0.87	0.87	-0.3	0.69	0.65	0.68	-0.68	-0.02	0.3		0.41	-0.33	0.72	-0.61	-0.77	0.47	0.56	0.58
Net Tangible Assets	0.88	0.95	0.27	-0.72	0.51	0.41	0.53	-0.17	0.1	0.9	0.62	-0.76	0.24	0.06	0.41		-0.67	0.58	-0.66	-0.84	0.97	0.94	0.1
Long Term Debt Total	-0.58	-0.56	0.08	0.4	-0.1	-0.42	-0.57	0.05	-0.14	-0.6	-0.56	0.63	-0.38	0.06	-0.33	-0.67		-0.61	0.5	0.62	-0.54	-0.57	-0.28
Capital Surpluse	0.71	0.5	0.15	-0.44	-0.3	0.82	0.83	-0.18	0.49	0.72	0.71	-0.71	0.19	0.32	0.72	0.58	-0.61		-0.69	-0.84	0.6	0.62	0.56
Deferred Long Term Liab	-0.69	-0.58	-0.06	0.46	-0.03	-0.59	-0.66	0.12	-0.33	-0.71	-0.65	0.71	-0.19	-0.17	-0.61	-0.66	0.5	-0.69		0.81	-0.7	-0.71	-0.35
Short Long Term Debt	-0.89	-0.74	-0.07	0.61	-0.07	-0.74	-0.82	0.16	-0.41	-0.9	-0.81	0.88	-0.2	-0.2	-0.77	-0.84	0.62	-0.84	0.81		-0.87	-0.88	-0.43
Net Invested Capital	0.92	0.89	0.26	-0.67	0.42	0.46	0.51	-0.15	0.25	0.94	0.67	-0.77	0.18	0.11	0.47	0.97	-0.54	0.6	-0.7	-0.87		0.98	0.24
Net Working Capital	0.96	0.82	0.17	-0.6	0.29	0.55	0.56	-0.22	0.41	0.97	0.69	-0.8	0.15	0.1	0.56	0.94	-0.57	0.62	-0.71	-0.88	0.98		0.37
Capital Stock	0.43	-0.12	-0.46	0.2	-0.67	0.62	0.4	-0.06	0.92	0.42	0.46	-0.4	-0.04	0.18	0.58	0.1	-0.28	0.56	-0.35	-0.43	0.24	0.37

Click cells to compare fundamentals

About Apyx Medical Financial Statements

Apyx Medical investors use historical fundamental indicators, such as Apyx Medical's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Apyx Medical. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	5.1 M	5.4 M
Stock Based Compensation To Revenue	0.10	0.10

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Apyx Stock Based Compensation from 2010 to 2024

Latest Apyx Medical's Stock Based Compensation Growth Pattern

Apyx Stock Based Compensation Regression Statistics

Apyx Stock Based Compensation History

Other Fundumenentals of Apyx Medical

Apyx Medical Stock Based Compensation component correlations

About Apyx Medical Financial Statements

Also Currently Popular

Additional Tools for Apyx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY